ReviewOncoTargets and therapy2020

Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects.

Hong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.